Prognostic Value of Pretreatment Skeletal Muscle Mass Index in Esophageal Cancer Patients: A Meta-Analysis

References

• Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM, Jensen ET, Lund JL, Pasricha S, Runge T, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the united states. Gastroenterology. 2015;149(7):1731–41.e3. doi: 10.1053/j.gastro.2015.08.045
   PubMed Web of Science ®Google Scholar
• Peery AF, Crockett SD, Murphy CC, Jensen ET, Kim HP, Egberg MD, Lund JL, Moon AM, Pate V, Barnes EL, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states: update 2021. Gastroenterology. 2022;162(2):621–44. doi:10.1053/j.gastro.2021.10.017
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53. doi: 10.1002/ijc.31937
   PubMed Web of Science ®Google Scholar
• Erratum. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(313) doi:10.3322/caac.21609
   Web of Science ®Google Scholar
• Keeble S, Abel GA, Saunders CL, McPhail S, Walter FM, Neal RD, Rubin GP, Lyratzopoulos G. Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a National Audit of cancer diagnosis in primary care. Int J Cancer. 2014;135(5):1220–8. doi:10.1002/ijc.28763
   PubMed Web of Science ®Google Scholar
• Atsumi Y, Kawahara S, Kakuta SHO, Onodera A, Hara K, Kazama K, Numata M, Aoyama T, Tamagawa A, Tamagawa H, et al. Low preoperative albumin-to-globulin ratio is a marker of poor prognosis in patients with esophageal cancer. In Vivo. 2021;35(6):3555–61. doi:10.21873/invivo.12658
   PubMed Web of Science ®Google Scholar
• Wang Y, Li P, Li J, Lai Y, Zhou K, Wang X, Che G. The prognostic value of pretreatment glasgow prognostic score in patients with esophageal cancer: a meta-analysis. CMAR. 2019;11:8181–90. doi:10.2147/CMAR.S203425
   Web of Science ®Google Scholar
• Wang Y, Chen L, Wu Y, Li P, Che G. The prognostic value of modified glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis. Nutr Cancer. 2020;72(7):1146–54. doi:10.1080/01635581.2019.1677925
   PubMed Web of Science ®Google Scholar
• Takao Koji, Konishi H, Fujiwara H, Shiozaki A, Shoda K, Kosuga T, Kubota T, Arita T, Morimura Ryo, Murayama Y, et al. Clinical significance of prognostic nutritional index in the treatment of esophageal squamous cell carcinoma. In Vivo. 2020;34(6):3451–7. doi:10.21873/invivo.12184
   PubMed Web of Science ®Google Scholar
• Wang B, Jiang XW, Tian DL, Zhou N, Geng W. Combination of haemoglobin and prognostic nutritional index predicts the prognosis of postoperative radiotherapy for esophageal squamous cell carcinoma. CMAR. 2020;12:8589–97. doi:10.2147/CMAR.S266821
   Web of Science ®Google Scholar
• Zhao Y, Shen W, Song C, Su J, Wu P, Wang X, Yan K, Xu J, Zhu S. Prognostic significance of prognostic nutritional index in esophageal squamous cell carcinoma patients undergoing radical radiotherapy: a propensity score matching analysis. Nutr Cancer. 2021;1–10. doi:10.1080/01635581.2021.1982997
   Web of Science ®Google Scholar
• Hirahara N, Matsubara T, Fujii Y, Kaji S, Hyakudomi R, Yamamoto T, Uchida Y, Miyazaki Y, Ishitobi K, Kawabata Y, et al. Geriatric nutritional risk index as a prognostic marker of pTNM-stage I and II esophageal squamous cell carcinoma after curative resection. Oncotarget. 2020;11(29):2834–46. doi:10.18632/oncotarget.27670
   PubMedGoogle Scholar
• Wang Y, Wang L, Fang M, Li J, Song T, Zhan W, Xu H. Prognostic value of the geriatric nutritional risk index in patients exceeding 70 years old with esophageal squamous cell carcinoma. Nutr Cancer. 2020;72(4):620–6. doi: 10.1080/01635581.2019.1650189
   PubMed Web of Science ®Google Scholar
• Di Giorgio A, Rotolo S, Cintoni M, Rinninella E, Pulcini G, et al. The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2021; doi:10.1016/j.ejso.2021.10.008
   Web of Science ®Google Scholar
• Li H, Dai J, Lan T, Liu H, Wang J, Cai B, Xu L, Yuan K, Wang G, Wu H, et al. Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection. Clin Nutr. 2021;40(6):3891–900. doi: 10.1016/j.clnu.2021.04.038
   PubMed Web of Science ®Google Scholar
• Yeh K-Y, Ling HH, Ng S-H, Wang C-H, Chang P-H, Chou W-C, Chen F-P, Lin Y-C. Role of the appendicular skeletal muscle index for predicting the recurrence-free survival of head and neck cancer. Diagnostics (Basel). 2021;11(2):309. doi:10.3390/diagnostics11020
   PubMedGoogle Scholar
• Su H, Ruan J, Chen T, Lin E, Shi L. CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging. 2019;19(1):82. doi: 10.1186/s40644-019-0270-0
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi: 10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi: 10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101. doi:10.2307/2533446
   PubMed Web of Science ®Google Scholar
• Paireder M, Asari R, Kristo I, Rieder E, Tamandl D, Ba-Ssalamah A, Schoppmann SF. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Ejso. 2017;43(2):478–84. doi:10.1016/j.ejso.2016.11.015
   PubMed Web of Science ®Google Scholar
• Järvinen T, Ilonen I, Kauppi J, Volmonen K, Salo J, Räsänen J. Low skeletal muscle mass in stented esophageal cancer predicts poor survival: a retrospective observational study. Thorac Cancer. 2018;9(11):1429–36. doi: 10.1111/1759-7714.12855
   PubMed Web of Science ®Google Scholar
• Sato S, Kunisaki C, Suematsu H, Tanaka Y, Miyamoto H, Kosaka T, Yukawa N, Tanaka K, Sato K, Akiyama H, et al. Impact of sarcopenia in patients with unresectable locally advanced esophageal cancer receiving chemoradiotherapy. In Vivo. 2018;32(3):603–10. doi: 10.21873/invivo.11282
   PubMed Web of Science ®Google Scholar
• Oguma J, Ozawa S, Kazuno A, Yamamoto M, Ninomiya Y, Yatabe K. Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma. Dis Esophagus. 2019;32(7) doi:10.1093/dote/doy104
   Web of Science ®Google Scholar
• Onishi S, Tajika M, Tanaka T, Hirayama Y, Hara K, Mizuno N, Kuwahara T, Okuno N, Inaba Y, Kodaira T, et al. Prognostic significance of sarcopenia in patients with unresectable advanced esophageal cancer. JCM. 2019;8(10):1647. doi:10.3390/jcm810
   Google Scholar
• Takahashi K, Watanabe M, Kozuki R, Toihata T, Okamura A, Imamura Y, Mine S, Ishizuka N. Prognostic significance of skeletal muscle loss during early postoperative period in elderly patients with esophageal cancer. Ann Surg Oncol. 2019;26(11):3727–35. doi: 10.1245/s10434-019-07616-0
   PubMed Web of Science ®Google Scholar
• Huang C-H, Lue K-H, Hsieh T-C, Liu S-H, Wang T-F, Peng T-C. Association between sarcopenia and clinical outcomes in patients with esophageal cancer under neoadjuvant therapy. Anticancer Res. 2020;40(2):1175–81. doi: 10.21873/anticanres.14060
   PubMed Web of Science ®Google Scholar
• Mallet R, Modzelewski R, Lequesne J, Mihailescu S, Decazes P, Auvray H, Benyoucef A, Di Fiore F, Vera P, Dubray B, et al. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer. Radiat Oncol. 2020;15(1):116 doi:10.1186/s13014-020-01545-z
   PubMed Web of Science ®Google Scholar
• Yoon HG, Oh D, Ahn YC, Noh JM, Pyo H, Cho WK, Song YM, Park M, Hwang NY, Sun J-M, et al. Prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer. Cancers. 2020;12(4):925. doi:10.3390/cancers12040
   PubMed Web of Science ®Google Scholar
• Fehrenbach U, Wuensch T, Gabriel P, Segger L, Yamaguchi T, Auer TA, Beetz NL, Denecke C, Kröll D, Raakow J, et al. CT body composition of sarcopenia and sarcopenic obesity: predictors of postoperative complications and survival in patients with locally advanced esophageal adenocarcinoma. Cancers. 2021;13(12):2921. doi:10.3390/cancers1312
   PubMed Web of Science ®Google Scholar
• Kemper M, Molwitz I, Krause L, Reeh M, Burdelski C, Kluge S, Yamamura J, Izbicki JR, de Heer G. Are muscle parameters obtained by computed tomography associated with outcome after esophagectomy for cancer? Clin Nutr. 2021;40(6):3729–40. doi: 10.1016/j.clnu.2021.04.040
   PubMed Web of Science ®Google Scholar
• Liang H, Peng H, Chen L. Prognostic value of sarcopenia and systemic inflammation markers in patients undergoing definitive radiotherapy for esophageal cancer. CMAR. 2021;13:181–92. doi:10.2147/CMAR.S288522
   Web of Science ®Google Scholar
• Peng H, Tan X. The prognostic significance of sarcopenia and the neutrophil-to-lymphocyte ratio in elderly patients with esophageal squamous cell carcinoma. Cancer Manag Res. 2021;13:3209–18. doi: 10.2147/cmar.S302274
   PubMed Web of Science ®Google Scholar
• Sakai M, Sohda M, Saito H, Ubukata Y, Nakazawa N, Kuriyama K, Hara K, Sano A, Ogata K, Yokobori T, et al. Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer. Am J Surg. 2021;221(1):149–54. doi: 10.1016/j.amjsurg.2020.05.029
   PubMed Web of Science ®Google Scholar
• Tan X, Peng H, Gu P, Chen M, Wang Y. Prognostic significance of the l3 skeletal muscle index and advanced lung cancer inflammation index in elderly patients with esophageal cancer. Cancer Manag Res. 2021;13:3133–43. doi: 10.2147/cmar.S304996
   PubMed Web of Science ®Google Scholar
• Wakefield CJ, Hamati F, Karush JM, Arndt AT, Geissen N, Liptay MJ, Borgia JA, Basu S, Seder CW. Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer. J Thorac Dis. 2021;13(2):861–9. doi: 10.21037/jtd-20-2608
   PubMed Web of Science ®Google Scholar
• Xu Y-Y, Zhou X-L, Yu C-H, Wang W-W, Ji F-Z, He D-C, Zhu W-G, Tong Y-S. Association of sarcopenia with toxicity and survival in postoperative recurrent esophageal squamous cell carcinoma patients receiving chemoradiotherapy. Front Oncol. 2021;11 doi:10.3389/fonc.2021.655071
   Web of Science ®Google Scholar
• Bekki T, Abe T, Amano H, Hattori M, Kobayashi T, Nakahara M, Ohdan H, Noriyuki T. Impact of low skeletal muscle mass index and perioperative blood transfusion on the prognosis for HCC following curative resection. BMC Gastroenterol. 2020;20(1):328. doi: 10.1186/s12876-020-01472-z
   PubMed Web of Science ®Google Scholar
• Schaffler-Schaden D, Mittermair C, Birsak T, Weiss M, Hell T, Schaffler G, Weiss H. Skeletal muscle index is an independent predictor of early recurrence in non-obese colon cancer patients. Langenbecks Arch Surg. 2020;405(4):469–77. doi: 10.1007/s00423-020-01901-3
   PubMed Web of Science ®Google Scholar
• Sui K, Okabayshi T, Iwata J, Morita S, Sumiyoshi T, Iiyama T, Shimada Y. Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy. Surg Today. 2018;48(5):545–51. doi: 10.1007/s00595-017-1622-7
   PubMed Web of Science ®Google Scholar
• Deng HY, Zha P, Peng L, Hou L, Huang KL, et al. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis. Dis Esophagus. 2019;32 doi:10.1093/dote/doy115
   Web of Science ®Google Scholar
• Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY). 2012;4(8):535–46. doi: 10.18632/aging.100482
   PubMedGoogle Scholar
• Lin J-X, Lin J-P, Xie J-W, Wang J-b, Lu J, Chen Q-Y, Cao L-l, Lin M, Tu R, Zheng C-H, et al. Prognostic value and association of sarcopenia and systemic inflammation for patients with gastric cancer following radical gastrectomy. Oncologist. 2019;24(11):e1091–e1101. doi:10.1634/theoncologist.2018-0651
   PubMed Web of Science ®Google Scholar
• Patel HJ, Patel BM. TNF-α and cancer cachexia: molecular insights and clinical implications. Life Sci. 2017;170:56–63. doi: 10.1016/j.lfs.2016.11.033
   PubMed Web of Science ®Google Scholar
• Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006;147(9):4160–8. doi: 10.1210/en.2006-0251
   PubMed Web of Science ®Google Scholar